Tradestie Institutional Equity Comparison Engine

ACAD vs ASTI โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ACAD Overall Edge

ACAD Captures Institutional Edge (2โ€“2 Pillars ยท 8โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Acadia Pharmaceuticals Inc. (ACAD) driven by superior Growth & Margin, Momentum & Technical while ASTI counters with relative strength in Valuation, Options & Structure. Fundamentally, ACAD trades at 15.8x Forward P/E with 10.2% operating margin (+22.8% YoY revenue) versus ASTI at 14.4x Forward P/E and -2759.6% operating margin (+514.3% YoY). In options structure, ACAD sits in BREAKDOWN (6th %ile IV; Dealer Gamma Walls on Pro) against ASTI sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner ASTI
ACAD 15.8x vs ASTI 14.4x Fwd P/E
Growth & Margin Winner ACAD
Op Margin 10.2% vs -2759.6% ยท YoY +22.8% vs +514.3%
Momentum & Technical Winner ACAD
1Y -25.9% vs -52.4% ยท 52W Pos 8% vs 0%
Options & Structure Winner ASTI
BREAKDOWN (6th %ile IV) vs UNCLASSIFIED (<1st %ile IV)
ACAD NASDAQ
Acadia Pharmaceuticals Inc.
Pharmaceutical Preparations
$17.11
-2.73% 1D
Market Cap $3.0B
1M Return -15.76%
1Y Return -25.93%
Forward P/E 15.8x
Unified AI Score
44.8 / 100 HOLD
Tech 38.0 Fund 54.0 Flow 67.0 Mom 60.0
ASTI NASDAQ
Ascent Solar Technologies, Inc. Common Stock
Semiconductors & Related Devices
$0.77
-9.55% 1D
Market Cap $12.6M
1M Return -56.38%
1Y Return -52.35%
Forward P/E 14.4x
Unified AI Score
44.5 / 100 HOLD
Tech 25.0 Fund 46.0 Flow 59.0 Mom 59.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ACAD -25.93% ASTI -52.35% Spread: +26.42 pp (ACAD Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period ACAD Revenue ASTI Revenue ACAD Op. Margin ASTI Op. Margin Margin Edge
FY2018 $220M $0M -110.6% -761.8% ACAD
FY2019 $340M $0M -72.7% -509.6% ACAD
FY2020 $440M $0M -64.9% -3684.8% ACAD
FY2021 $480M $0M -35.2% -1446.3% ACAD
FY2022 $520M $0M -43.2% -1394.8% ACAD
FY2023 $730M $0M -10.1% -3413.6% ACAD
FY2024 $960M $0M 24.1% -20378.5% ACAD
FY2025 $1.07B $0M 9.8% -10256.7% ACAD

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ACAD (8) vs ASTI (2)
Institutional Metric ACAD ASTI Criterion Row Winner
Market Capitalization Scale $3.0B $12.6M Larger Scale ACAD
Trailing P/E Ratio Valuation 8.3x 14.4x Lower Multiple ACAD
Forward P/E Ratio Valuation 15.8x 14.4x Lower Multiple ASTI
Revenue Growth (YoY) Growth +22.8% +514.3% Higher Growth ASTI
Operating Margin (TTM) Profitability 10.2% -2759.6% Higher Margin ACAD
Net Profit Margin Profitability 30.1% 0.0% Higher Margin ACAD
Return on Equity (ROE) Capital Efficiency 31.4% -111.3% Higher ROE ACAD
52-Week Range Position Momentum 8% ($16โ€“$31) 0% ($1โ€“$10) Stronger Trend ACAD
Beta / 30D Volatility Risk Regime 0.15ฮฒ ยท 90% Vol 4.37ฮฒ ยท 123% Vol Lower Realized Risk ACAD
Unified Institutional Score Composite Signal 44.8 / 100 (HOLD) 44.5 / 100 (HOLD) Higher Composite ACAD

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ACAD vs ASTI Buy Guide
ACAD BREAKDOWN
62d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 6th %ile
IV Regime Compressed (<25th %ile)
Live ACAD Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ASTI UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile <1st %ile
IV Regime Compressed (<25th %ile)
Live ASTI Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ACAD nor ASTI registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.